IMPACT
IMPACT

“My AFAR grant was instrumental in building my research career, and I am not alone. AFAR has built the pipeline of investigators leading labs at top institutions nationwide, where their research will help us all live healthier as we age.” - David Sinclair, Ph.D., 
2000 AFAR Research Grant for Junior Faculty and Current Board Member; Professor, Harvard Medical School.

 

 

TAKING RISKS.

DRIVING INNOVATION.

MAKING IMPACT.

 

AFAR invests in extraordinary scientists willing to take risks, confident that their research will transform the future of healthy aging for us all.


AFAR’s Julie Martin Mid-Career Award in Aging Research in 2014 helped Satchidananda Panda, Ph.D. of the Salk Institute advance research on metabolism, our bodies’ daily or circadian rhythms, and the impact of time-restricted feeding  — suggesting lifestyle interventions that can prevent diseases associated with aging , as ex-plored in his new book The Circadian Code.
Supported by a 2016 Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging as well as a 2018 Irene Diamond Fund/AFAR Postdoctoral Transition Award in Aging, Jenna Bartley, Ph.D. of the University of Connecticut School of Medicine is studying how the drug metformin effects influenza vaccine responses and T-cell function in older patients — a promising path to improving immune health and resilience.

The recipient of both a 2006 AFAR Research Grant for Junior Faculty and a 2007 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award, Matt Kaeberlein, Ph.D. of the University of Washington is co-leading the novel Dog Aging Project, which studies how the drug rapamycin can extend canine longevity and human healthspan  —  as show-cased in a New York Times cover story.

A Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging in 2016 helped advance research by Marissa Schafer, Ph.D. of the Mayo Clinic that explores how eliminating senescent cells, which are central drivers of aging processes, could serve as a therapeutic for idiopathic pulmonary fibrosis  —  a fatal disease that severely influences pulmonary and physical health.

 

For more than three decades, AFAR has built and advanced the field of biomedical research on healthy aging.

 

We accomplish this by supporting cutting-edge research that many private and public funders will not.

 

We accomplish this thanks to
 YOUR SUPPORT. 

 

 

 



View MoreBACK TO TOP

STAY CONNECTED